ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aruvant partners with Lonza to manufacture sickle cell disease treatment
January 20, 2021Clinical-stage biopharmaceutical firm Aruvant Sciences and Lonza have entered a strategic long-term manufacturing agreement for the former’s one-time investigational gene therapy for sickle cell disease (SCD), ARU-1801. -
Asia HealthTech momentum continues unabated closing H1 2019 at $2.5B
July 09, 2019Galen Growth Asia shared 2019 Half Year Asia Healthtech Landscape report, the bi-annual go-to-reference for key trends and insights for investors, enterprises and start-ups -
Asia HealthTech momentum continues unabated closing H1 2019 at US$2.5B
July 08, 2019Galen Growth Asia shared 2019 Half Year Asia Healthtech Landscape report, the bi-annual go-to-reference for key trends and insights for investors, enterprises and start-ups -
Manufacturing hiccup in China trips up Sanofi's vaccine sales momentum
May 17, 2018After a strong 2017, Sanofi Pasteur got off to a less-than-stellar start this year. In China, inspectors put a temporary kibosh on imports of the pediatric shot Pentaxim,
Pharma Sources Insight January 2025
